Quantitating the Impact of Plerixafor Alone or in Combination With Bortezomib on Plasma Cell Mobilization and the Subsequent Impact on HLA Antibody Levels
Phase of Trial: Phase I/II
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Plerixafor (Primary) ; Bortezomib
- Indications Stem cell mobilisation
- Focus Pharmacodynamics
- 24 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 24 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 18 Aug 2015 New trial record